ERS Genomics team expands with new hire, Dr. Ralph Vogelsang
DUBLIN, Feb. 3, 2022 /PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to welcome latest hire, Dr. Ralph Vogelsang.
- DUBLIN, Feb. 3, 2022 /PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to welcome latest hire, Dr. Ralph Vogelsang.
- ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property.
- Prior to ERS, Ralph held several positions in sales, scientific-support, and business development at Pacific Biosciences.
- Dr. Ralph Vogelsang, ERS made the following statement:'The team at ERS is making huge progress increasing global access to the Nobel Prize winning CRISPR/Cas9 system.